| scholarly article | Q13442814 |
| P2093 | author name string | Sung-Hoon Lee | |
| Ok-Jun Lee | |||
| Chang Gok Woo | |||
| Jieun Yun | |||
| Hyung Geun Song | |||
| Ho-Chang Lee | |||
| Hyun-Jun Lee | |||
| Seung-Myoung Son | |||
| Hye Sook Han | |||
| Young-Mi Gu | |||
| Young Hyun Lim | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas | Q24669773 | ||
| Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo | Q24675613 | ||
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
| Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 | ||
| MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6 | Q28116258 | ||
| Extracellular N-domain alone can mediate specific heterophilic adhesion between members of the carcinoembryonic antigen family, CEACAM6 and CEACAM8 | Q28138736 | ||
| CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells | Q28238822 | ||
| The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 | ||
| Sequence and glycosylation site identity of two distinct glycoforms of nonspecific cross-reacting antigen as demonstrated by sequence analysis and fast atom bombardment mass spectrometry | Q28285587 | ||
| Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles | Q29615957 | ||
| Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers | Q33268089 | ||
| Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells | Q33525547 | ||
| Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity | Q34044546 | ||
| First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement | Q34324970 | ||
| Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix | Q34536701 | ||
| CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas | Q35075187 | ||
| MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. | Q35201318 | ||
| Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma | Q36385644 | ||
| pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents | Q36404430 | ||
| pH (low) insertion peptide (pHLIP) targets ischemic myocardium | Q36512156 | ||
| pHLIP peptide targets nanogold particles to tumors | Q36535248 | ||
| AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2 | Q36670941 | ||
| Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer. | Q37168610 | ||
| pHLIP-mediated translocation of membrane-impermeable molecules into cells. | Q37340596 | ||
| Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells | Q37422870 | ||
| RNA interference in the clinic: challenges and future directions | Q37821230 | ||
| Action and reaction: the biological response to siRNA and its delivery vehicles | Q37976576 | ||
| Extracellular vesicles as drug delivery systems: lessons from the liposome field | Q38237168 | ||
| Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. | Q38722440 | ||
| A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties | Q38929320 | ||
| Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer | Q39279302 | ||
| The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours | Q39512984 | ||
| CEACAM6 gene expression in intrahepatic cholangiocarcinoma | Q40251499 | ||
| Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). | Q40365821 | ||
| Peptide nucleic acid (PNA). A DNA mimic with a peptide backbone | Q40760039 | ||
| Dual role of carcinoembryonic antigen-related cell adhesion molecule 6 expression in predicting the overall survival of gastric cancer patients | Q41534014 | ||
| Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice. | Q43763050 | ||
| Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic Significance | Q44598294 | ||
| Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6. | Q46019803 | ||
| Redefined nomenclature for members of the carcinoembryonic antigen family | Q48738225 | ||
| Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. | Q51743199 | ||
| Breast carcinoma with amplified HER2: a gene expression signature specific for trastuzumab resistance and poor prognosis. | Q53463534 | ||
| Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. | Q54700470 | ||
| Antibody By114 is selective for the 90 kD PI-linked component of the CD66 antigen: a new reagent for the study of paroxysmal nocturnal haemoglobinuria | Q70565673 | ||
| Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker | Q73499503 | ||
| CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions | Q81436009 | ||
| P433 | issue | 1 | |
| P921 | main subject | gene silencing | Q1431332 |
| P304 | page(s) | 11607 | |
| P577 | publication date | 2019-09-02 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma | |
| P478 | volume | 9 |
Search more.